In vivo effects of olanzapine on striatal dopamine D 2 /D 3 receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study

Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine

Lars Farde · Archives of General Psychiatry · 1992 · 1.4K citations

Medicine, Pharmacology, Psychiatry +15

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

Alain Schotte, Paul Janssen, W Gommeren et al. · Psychopharmacology · 1996 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine

Frank P. Bymaster, David O. Calligaro, Julie F. Falcone et al. · Neuropsychopharmacology · 1996 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients

Anna Nordström, Lars Farde, Frits‐Axel Wiesel et al. · Biological Psychiatry · 1993 · 530 citations

Medicine, Pharmacology, Psychiatry +17

BindingDB Entry 4838: Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.

PubMed · 2011 · 335 citations · Full text

Medicine, Pharmacology, Psychiatry +16